ONCT
Oncternal Therapeutics Inc
NASDAQ: ONCT · HEALTHCARE · BIOTECHNOLOGY
$0.53
+0.00% today
Updated 2026-04-30
Market cap
$1.56M
P/E ratio
—
P/S ratio
0.72x
EPS (TTM)
$-11.69
Dividend yield
—
52W range
$0 – $0
Volume
—
Oncternal Therapeutics Inc (ONCT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.87M | $3.78M | $7.50M | $7.13M | $13.53M | $14.73M | $60.61M | $14.74M | — | — | — | — | $-2.51M | $1.67M | $2.52M | $2.42M | $3.38M | $4.32M | $1.49M | $785000.00 |
| Revenue growth (YoY) | — | +102.6% | +98.4% | -5.0% | +89.8% | +8.9% | +311.5% | -75.7% | -100.0% | — | — | — | — | +166.7% | +50.6% | -3.8% | +39.2% | +27.9% | -65.5% | -47.3% |
| Cost of revenue | — | $1.57M | $773000.00 | $621000.00 | $649000.00 | $1.29M | $768000.00 | $1.05M | — | — | — | $43000.00 | $2.51M | $9.36M | $46000.00 | $10.16M | $12.00M | $169000.00 | $179000.00 | $29.75M |
| Gross profit | $1.87M | $2.21M | $6.73M | $6.50M | $12.88M | $13.44M | $59.84M | $13.68M | — | — | — | $-43000.00 | $-5.02M | $-7.69M | $2.48M | $-7.73M | $3.38M | $4.32M | $1.49M | $-28.97M |
| Gross margin | 100.0% | 58.4% | 89.7% | 91.3% | 95.2% | 91.2% | 98.7% | 92.8% | — | — | — | — | 200.0% | -459.3% | 98.2% | -318.9% | 100.0% | 100.0% | 100.0% | -3690.2% |
| R&D | $17.95M | $30.92M | $33.90M | $38.51M | $44.26M | $32.34M | $28.50M | $31.94M | $38.89M | $32.32M | $20.87M | $13.61M | $17.23M | $21.47M | $29.67M | $10.16M | $12.54M | $24.09M | $32.98M | $29.75M |
| SG&A | $7.21M | $9.85M | $11.35M | $13.50M | $23.11M | $27.75M | $17.42M | $15.44M | $10.85M | $11.28M | $9.48M | $8.23M | $8.71M | $9.19M | $9.39M | $7.29M | $8.37M | $11.60M | $13.46M | $12.55M |
| Operating income | $-23.29M | $-38.56M | $-38.52M | $-45.50M | $-54.48M | $-46.65M | $13.93M | $-33.69M | $-49.73M | $-43.60M | $-30.35M | $-21.84M | $-25.93M | $-30.66M | $-39.06M | $-33.11M | $-17.54M | $-31.37M | $-44.95M | $-41.71M |
| Operating margin | -1247.7% | -1019.5% | -513.2% | -638.6% | -402.8% | -316.7% | 23.0% | -228.6% | — | — | — | — | 1032.8% | -1831.2% | -1549.3% | -1365.3% | -519.8% | -726.9% | -3016.6% | -5313.9% |
| EBITDA | $-23.87M | $-38.86M | $-43.52M | $-50.40M | $-52.92M | $-44.71M | $16.87M | $-34.09M | $-48.98M | $-43.22M | $-39.31M | $-18.66M | $-17.70M | $-30.61M | $1.01M | $-33.11M | $-17.54M | $-31.33M | $-44.24M | $2.23M |
| EBITDA margin | -1278.7% | -1027.4% | -579.9% | -707.3% | -391.2% | -303.5% | 27.8% | -231.3% | — | — | — | — | 704.7% | -1828.4% | 40.0% | -1365.3% | -519.8% | -726.1% | -2969.5% | 284.7% |
| EBIT | $-23.29M | $-38.56M | $-38.52M | $-45.50M | $-54.48M | $-46.49M | $15.29M | $-35.13M | $-49.73M | $-43.60M | $-39.41M | $-18.70M | $-17.72M | $-30.66M | $-6.58M | $-48.13M | $-17.54M | $-31.37M | $-44.95M | $-39.48M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $16000.00 | $33000.00 | $702000.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-22.35M | $-36.84M | $-35.51M | $-40.36M | $-51.78M | $-46.26M | $15.29M | $-33.29M | $-27.07M | $-42.11M | $-39.41M | $-18.70M | $-17.72M | $-30.44M | $-38.42M | $-15.91M | $-17.21M | $-31.30M | $-43.39M | $-39.48M |
| Net income growth (YoY) | — | -64.8% | +3.6% | -13.7% | -28.3% | +10.7% | +133.1% | -317.7% | +18.7% | -55.5% | +6.4% | +52.5% | +5.2% | -71.7% | -26.2% | +58.6% | -8.2% | -81.9% | -38.6% | +9.0% |
| Profit margin | -1197.0% | -974.1% | -473.2% | -566.4% | -382.8% | -314.0% | 25.2% | -225.9% | — | — | — | — | 705.9% | -1818.3% | -1523.9% | -656.2% | -509.9% | -725.4% | -2912.3% | -5029.2% |